Orthofix Medical (OFIX) 10% Owner LLC Buys $1.7M of Stock

Juniper Investment Company, LLC bought 190,000 shares of Orthofix Medical Inc. (NasdaqGS: OFIX) on September 21, 2026, for about $1.68 million. This purchase increases their total holdings to over 4.4 million shares. The shares were bought at an average price of $8.86 each.

Inside Juniper Investment Company's Trade

As a 10% owner of Orthofix, Juniper's recent buy reflects confidence in the company's potential. This transaction is not part of a planned strategy, indicating a more spontaneous decision to increase their stake in the medical technology firm.

Other Institutional Activity in Orthofix Medical

Engine Capital Management, LP added 184,854 shares, bringing its total to about 4.6 million shares worth approximately $43.1 million. Juniper Investment Company itself had previously increased its holdings by 465,690 shares, now valued at about $41.8 million. Blackrock Inc. also grew its stake by 118,691 shares, totaling about 3.3 million shares worth around $31.3 million. These moves show a general uptick in institutional interest in Orthofix.

Orthofix Medical Inc. Stock Up 7.7%

At the time of Juniper's purchase, Orthofix shares were trading at $8.86, close to their 52-week low of $8.50. This suggests that the stock has been under pressure in the market, and Juniper's buy might be seen as a vote of confidence in the company's recovery potential. The stock price is well below its 52-week high of $16.99.

Recent Earnings

Orthofix reported revenue of $833.2 million, reflecting a growth rate of 3.8%. However, the company has faced challenges, with an EPS of -$1.52 and a net margin of -7.4%. The next earnings report is scheduled for November 3, 2026, which could provide more insights into the company's performance.

Insider Buying and Selling at Orthofix Medical Inc.

On the same day as Juniper's purchase, it also reported buying an additional 310,000 shares, valued at about $2.73 million. This shows a strong commitment from the firm to increase its stake. In contrast, Officer Patrick G. Fisher sold 150 shares on October 1, 2026, at a price of $9.44, totaling approximately $1,416.

Analysts Set New Price Targets

On August 10, 2026, Canaccord Genuity maintained a "Buy" rating with a price target of $13.0, down from a prior target of $18.0. Barrington Research also maintained an "Outperform" rating with a new target of $17.0, up from $15.0 on July 6, 2026. The current consensus indicates a mean target price of $13.0 from four analysts.

About Orthofix Medical

Orthofix Medical Inc. is a medical technology firm that specializes in orthopedic and spine solutions. Headquartered in Lewisville, Texas, the company operates globally, addressing the needs of patients through its innovative products in the Global Spine and Global Limb Reconstruction segments. Juniper's increased stake suggests a belief in the company's future growth amid challenging market conditions.

Bottom Line

Investors will be watching Orthofix closely as the company prepares for its next earnings report on November 3, 2026. Juniper's recent purchases highlight a bullish outlook from significant stakeholders. Note that this Form 4 filing reflects past transactions and may not represent current positions.